These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 27012469)

  • 1. Depending on maternal Yap.
    Posfai E; Rossant J
    Cell Res; 2016 Apr; 26(4):393-4. PubMed ID: 27012469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Inter-α-inhibitor activates the Yes tyrosine kinase and YAP/TEAD transcriptional complex in mouse embryonic stem cells.
    Pijuan-Galitó S; Tamm C; Annerén C
    J Biol Chem; 2014 Nov; 289(48):33492-502. PubMed ID: 25301940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm.
    Vassilev A; Kaneko KJ; Shu H; Zhao Y; DePamphilis ML
    Genes Dev; 2001 May; 15(10):1229-41. PubMed ID: 11358867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD.
    Mesrouze Y; Bokhovchuk F; Meyerhofer M; Fontana P; Zimmermann C; Martin T; Delaunay C; Erdmann D; Schmelzle T; Chène P
    Elife; 2017 Apr; 6():. PubMed ID: 28430104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Abl antagonizes the YAP oncogenic function.
    Keshet R; Adler J; Ricardo Lax I; Shanzer M; Porat Z; Reuven N; Shaul Y
    Cell Death Differ; 2015 Jun; 22(6):935-45. PubMed ID: 25361080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into the YAP and TEAD complex.
    Li Z; Zhao B; Wang P; Chen F; Dong Z; Yang H; Guan KL; Xu Y
    Genes Dev; 2010 Feb; 24(3):235-40. PubMed ID: 20123905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4.
    Li Y; Liu S; Ng EY; Li R; Poulsen A; Hill J; Pobbati AV; Hung AW; Hong W; Keller TH; Kang C
    Biochem J; 2018 Jun; 475(12):2043-2055. PubMed ID: 29760238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural Progenitor Cells Undergoing Yap/Tead-Mediated Enhanced Self-Renewal Form Heterotopias More Easily in the Diencephalon than in the Telencephalon.
    Saito K; Kawasoe R; Sasaki H; Kawaguchi A; Miyata T
    Neurochem Res; 2018 Jan; 43(1):180-189. PubMed ID: 28879493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properly dividing with YAP.
    Pfeifer GP
    Sci Signal; 2016 Mar; 9(417):fs3. PubMed ID: 26933061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting TEAD/YAP-transcription-dependent necrosis, TRIAD, ameliorates Huntington's disease pathology.
    Mao Y; Chen X; Xu M; Fujita K; Motoki K; Sasabe T; Homma H; Murata M; Tagawa K; Tamura T; Kaye J; Finkbeiner S; Blandino G; Sudol M; Okazawa H
    Hum Mol Genet; 2016 Nov; 25(21):4749-4770. PubMed ID: 28171658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different ways to regulate the yes-associated protein/TEA domain family member complex.
    Shu B; Zhai M; Deng C; Miao X; Fang Y; Liu S
    J Cell Biochem; 2018 Aug; 119(8):6323-6324. PubMed ID: 29744926
    [No Abstract]   [Full Text] [Related]  

  • 12. Tales from the Cryptkeeper: New Roles for Lats1/2 in Wnt-driven Homeostasis.
    Fu V; Guan KL
    Cell Stem Cell; 2020 May; 26(5):612-614. PubMed ID: 32386550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of SRC-1 phase separation suppresses YAP oncogenic transcription activity.
    Zhu G; Xie J; Fu Z; Wang M; Zhang Q; He H; Chen Z; Guo X; Zhu J
    Cell Res; 2021 Sep; 31(9):1028-1031. PubMed ID: 33850322
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell signalling: Double duty for Dishevelled.
    Du Toit A
    Nat Rev Mol Cell Biol; 2015 Jun; 16(6):326-7. PubMed ID: 25922901
    [No Abstract]   [Full Text] [Related]  

  • 15. Human embryology: Implantation barrier overcome.
    Rossant J
    Nature; 2016 May; 533(7602):182-3. PubMed ID: 27144361
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinct mechanisms regulate Cdx2 expression in the blastocyst and in trophoblast stem cells.
    Rayon T; Menchero S; Rollán I; Ors I; Helness A; Crespo M; Nieto A; Azuara V; Rossant J; Manzanares M
    Sci Rep; 2016 Jun; 6():27139. PubMed ID: 27256674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation Assay.
    Hammoud L; Adams JR; Loch AJ; Marcellus RC; Uehling DE; Aman A; Fladd C; McKee TD; Jo CEB; Al-Awar R; Egan SE; Rossant J
    Stem Cell Reports; 2016 Oct; 7(4):787-801. PubMed ID: 27618721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway.
    Li P; Silvis MR; Honaker Y; Lien WH; Arron ST; Vasioukhin V
    Genes Dev; 2016 Apr; 30(7):798-811. PubMed ID: 27013234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.
    Aylon Y; Gershoni A; Rotkopf R; Biton IE; Porat Z; Koh AP; Sun X; Lee Y; Fiel MI; Hoshida Y; Friedman SL; Johnson RL; Oren M
    Genes Dev; 2016 Apr; 30(7):786-97. PubMed ID: 27013235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Potential Structural Switch for Regulating DNA-Binding by TEAD Transcription Factors.
    Lee DS; Vonrhein C; Albarado D; Raman CS; Veeraraghavan S
    J Mol Biol; 2016 Jun; 428(12):2557-2568. PubMed ID: 27016204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.